Terms: = Kidney tumors AND PTEN, MMAC1, 5728, MGC11227, PTEN1, MHAM, P60484, BZS, ENSG00000171862 AND Staging
8 results:
1. Role of HHV-8 and mTOR pathway in post-transplant Kaposi sarcoma staging.
Hernández-Sierra A; Rovira J; Petit A; Moya-Rull D; Mazuecos MA; Sánchez-Fructuoso AI; Errasti P; Idoate MÁ; Cruzado JM; Vidal A; Diekmann F; Oppenheimer F; Campistol JM; Revuelta I
Transpl Int; 2016 Sep; 29(9):1008-16. PubMed ID: 27208691
[TBL] [Abstract] [Full Text] [Related]
2. Vimentin over-expression and carbonic anhydrase IX under-expression are independent predictors of recurrence, specific and overall survival in non-metastatic clear-cell renal carcinoma: a validation study.
Ingels A; Hew M; Algaba F; de Boer OJ; van Moorselaar RJ; Horenblas S; Zondervan P; de la Rosette JJ; Pilar Laguna Pes M
World J Urol; 2017 Jan; 35(1):81-87. PubMed ID: 27207480
[TBL] [Abstract] [Full Text] [Related]
3. Snail heterogeneity in clear cell renal cell carcinoma.
Zaldumbide L; Erramuzpe A; Guarch R; Pulido R; Cortés JM; López JI
BMC Cancer; 2016 Mar; 16():194. PubMed ID: 26951092
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic role of PPAR-γ and pten in the renal cell carcinoma.
Zhu C; Wei J; Tian X; Li Y; Li X
Int J Clin Exp Pathol; 2015; 8(10):12668-77. PubMed ID: 26722456
[TBL] [Abstract] [Full Text] [Related]
5. Mining tissue microarray data to uncover combinations of biomarker expression patterns that improve intermediate staging and grading of clear cell renal cell cancer.
Dahinden C; Ingold B; Wild P; Boysen G; Luu VD; Montani M; Kristiansen G; Sulser T; Bühlmann P; Moch H; Schraml P
Clin Cancer Res; 2010 Jan; 16(1):88-98. PubMed ID: 20028743
[TBL] [Abstract] [Full Text] [Related]
6. Molecular signatures of localized clear cell renal cell carcinoma to predict disease-free survival after nephrectomy.
Klatte T; Seligson DB; LaRochelle J; Shuch B; Said JW; Riggs SB; Zomorodian N; Kabbinavar FF; Pantuck AJ; Belldegrun AS
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):894-900. PubMed ID: 19240241
[TBL] [Abstract] [Full Text] [Related]
7. Using tumor markers to predict the survival of patients with metastatic renal cell carcinoma.
Kim HL; Seligson D; Liu X; Janzen N; Bui MH; Yu H; Shi T; Belldegrun AS; Horvath S; Figlin RA
J Urol; 2005 May; 173(5):1496-501. PubMed ID: 15821467
[TBL] [Abstract] [Full Text] [Related]
8. Using protein expressions to predict survival in clear cell renal carcinoma.
Kim HL; Seligson D; Liu X; Janzen N; Bui MH; Yu H; Shi T; Figlin RA; Horvath S; Belldegrun AS
Clin Cancer Res; 2004 Aug; 10(16):5464-71. PubMed ID: 15328185
[TBL] [Abstract] [Full Text] [Related]
